Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-275291 in early breast cancer
NCT00036621Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Primary completion
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rebimastat in breast cancer, sponsored by Bristol Myers Squibb. Status: terminated.
02
Drugs
rebimastat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00036621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036621.